Sponsor Pipeline

Shanghai Siponuoyin Biotechnology Co Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07188012 Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients Duchenne Muscular Dystrophy (DMD) Recruiting
Disease Areas
Duchenne Muscular Dystrophy (1)
Get alerts when Shanghai Siponuoyin Biotechnology Co Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free